All posts tagged "Gilead Sciences Inc."
-
1.8KBiotechCytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle
Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...
-
2.0K2BiotechCytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)
CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer...
-
4.7KBiotechEnzolytics (ENZC) Takes on HIV Heavyweight Gilead Sciences
The cocktail of drugs given to HIV patients has been dominated by Gilead Sciences (GILD) for over a decade. They are the...
-
1.6KBiotechAikido Pharma’s (AIKI) Clinical Trial Results Continues to Validates Gilead’s $21 Billion Purchase of Immunomedics
Aikido Pharma Inc. (NASDAQ: AIKI) announced excellent phase 1 data at the annual ASCO meeting. The data was presented by Dr. Scott...
-
2.1KBiotechCytoDyn’s Adjust Course to Emphasize Philippine EUA and Long Haulers
Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...
-
3.2K3BiotechCytoDyn Saves Lives & Reduces COVID-19 Hospital Duration
6 endpoints met after full data release so shorts double down on trial failure narrative Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...
-
17.4K2BiotechWading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
-
32.0K1BiotechCytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval
CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today. The company reported ...
- Stocks
Today’s Hot List: Gilead Sciences Inc. (NASDAQ:GILD), CorMedix, Inc. (NYSEMKT:CRMD), Public Storage (NYSE:PSA), Eros International Plc (NYSE:EROS), Yingli Green Energy Holding (NYSE:YGE)
Gilead Sciences Inc. (NASDAQ:GILD) on Nov 11, said its new Harvoni drug for hepatitis C achieved cure rates of 96 percent to...
- Stocks
Top News: Petroleo Brasileiro Petrobras (NYSE:PBR), Gilead Sciences Inc. (NASDAQ:GILD), Rudolph Technologies Inc. (NYSE:RTEC), Superior Energy Services, (NYSE:SPN), Invesco Mortgage Capital (NYSE:IVR)
Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) announces that its consolidated oil and gas production, in Brazil and abroad, reached 2 million 795...
